HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.

Fang ChengQiang LiJinglin WangLiu WangWei-Ming Li Fang Zeng

Published in: Disease markers (2022)

HCK could regulate immune cell infiltration in the microenvironment of AML and may act as a potential biomarker for the treatment and prognosis of AML patients.

Keyphrases

acute myeloid leukemia
end stage renal disease
ejection fraction
newly diagnosed
stem cells
prognostic factors
allogeneic hematopoietic stem cell transplantation
patient reported outcomes
acute lymphoblastic leukemia
risk assessment
patient reported